Keywords
Diabetes Mellitus, Type 2
Blood Glucose Self-Monitoring
Monitoring
Ambulatory
Hypoglycemia
Empowerment
Health Education
How to Cite
Abstract
Background: In type 2 diabetes beyond the state of chronic hyperglycemia, other indices of dysglycemia such as glycemic variability and recurrent episodes of hypoglycemia have been found to contribute to adverse outcomes.
Purpose: to compare glycometry under a stepped glycemic self-monitoring modality in patients with type 2 diabetes, in order to identify a prognostic factor to optimize glycemic control, based on the analysis of glycemic variability.
Methodology: case series, with a study sample of glycometric data of stepped self-monitoring in three subjects, during 5 years, with an average of 3,400 observed data. A multivariate linear model and post-hoc multiple comparisons tests were used. Glycemic variability was evaluated using mean blood glucose, standard deviation and coefficient of variation for each meal time.
Results: The total number of samples analyzed had a coefficient of variation lower than 36%. The three individuals presented different trends throughout the study period. The data collected leaned towards hypoglycemia. There were no significant differences in the 6 meal times.
Conclusions: In current practice the goal is to decrease glycemic variability, with low risk of hypoglycemia. Self-monitoring of blood glucose is useful to reduce the risk of hypoglycemia and improve glycemic control.
References
Daly A, Hovorka R. Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes Obes Metab. 2021;23(8):1722-32. https://doi.org/10.1111/dom.14418
Bode B, King A, Russell-Jones D, Billings LK. Leveraging advances in diabetes technologies in primary care: a narrative review. Ann Med. 2021;53(1):805-16. https://doi.org/10.1080/07853890.2021.1931427
Crasto W, Patel V, Davies MJ, Khunti K. Prevention of Microvascular Complications of Diabetes. Endocrinol Metab Clin North Am. 2021;50(3):431-55. https://doi.org/10.1016/j.ecl.2021.05.005
Kusunoki Y, Konishi K, Tsunoda T, Koyama H. Significance of Glycemic Variability in Diabetes Mellitus. Intern Med. 2022;61(3):281-90. https://doi.org/10.2169/internalmedicine.8424-21
Zhou Z, Sun B, Huang S, Zhu C, Bian M. Glycemic variability?: adverse clinical outcomes and how to improve it?? Cardiovasc Diabetol. 2020;19:1-14. https://doi.org/10.1186/s12933-020-01085-6
Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N, et al. Toward defining the threshold between low and high glucose variability in diabetes. Diabetes Care. 2017;40:832-8. https://doi.org/10.2337/dc16-1769
Lavalle-González FJ, Antillón-Ferreira C, Flores-Caloca O, Márquez-Rodríguez E, Yépez-Rodríguez AE, De Garza-Hernández N, et al. Recomendaciones del uso de monitoreo continuo y evaluación de la variabilidad glucémica en diabetes. Med Int Mex. 2020;36:185-98.
Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Glycaemic management in diabetes: old and new approaches. Lancet Diabetes Endocrinol. 2022;10(1):75-84. https://doi.org/10.1016/S2213-8587(21)00245-X
Almutairi N, Hosseinzadeh H, Gopaldasani V. The effectiveness of patient activation intervention on type 2 diabetes mellitus glycemic control and self-management behaviors: A systematic review of RCTs. Prim Care Diabetes. 2020;14(1):12-20. https://doi.org/10.1016/j.pcd.2019.08.009
Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):33762313. https://doi.org/10.1136/bmjdrc-2020-002032
Gallardo-Rincón H, Cantoral A, Arrieta A, Espinal C, Magnus MH, Palacios C, et al. Review: Type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention. Prim Care Diabetes. 2021;15(2):352-9. https://doi.org/10.1016/j.pcd.2020.10.001
Wang C, Lv L, Yang Y, Chen D, Liu G, Chen L, et al. Glucose fluctuations in subjects with normal glucose tolerance , impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2012;76:810-5. https://doi.org/10.1111/j.1365-2265.2011.04205.x
Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, et al. Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP). Diabetes Technol Ther. 2013;15:198-211. https://doi.org/10.1089/dia.2013.0051
Rodbard D. Glucose Variability: A review of clinical applications and Research Developments. Diabetes Technol Ther. 2018;20:S2-5. https://doi.org/10.1089/dia.2018.0092
Rodbard D. Hypo-and Hyperglycemia in Relation to the Mean, Standard Deviation, Coefficient of Variation, and Nature of the Glucose Distribution. Diabetes Technol Ther. 2012;14:868-76. https://doi.org/10.1089/dia.2012.0062
Rodbard D. Clinical interpretation of indices of quality ofglycemic control and glycemic Variability. Postgrad Med. 2015;123:107-18. https://doi.org/10.3810/pgm.2011.07.2310
Jacober SJ, Zhang Q, Ph D, Wolka LL. Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data. Diabetes Technol Ther. 2012;14:1008-12. https://doi.org/10.1089/dia.2012.0099
Ohara M, Kohata Y, Nagaike H, Koshibu M, Gima H, Hiromura M. Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross ? sectional study. Diabetol Metab Syndr. 2019;1-10. https://doi.org/10.1186/s13098-019-0425-y
Caprnda M, Mesarosova D, Ortega PF, Krahulec B, Egom E, Rodrigo L, et al. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus. Folia Med (Plovdiv). 2017;59:270-8. https://doi.org/10.1515/folmed-2017-0048
Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178-81. https://doi.org/10.1016/j.jdiacomp.2004.10.001
American Association of Diabetes. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(supl. 1):S15-33. https://doi.org/10.2337/dc21-s002
Kröger J, Reichel A, Siegmund T, Ziegler R. Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care. J Diabetes Sci Technol. 2020;14(3):586-94. https://doi.org/10.1177/1932296819883032
Grant AK, Golden L. Technological Advancements in the Management of Type 2 Diabetes. Curr Diab Rep. 2019;19:163. https://doi.org/10.1007/s11892-019-1278-3
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo